HER2 Immunohistochemistry in Invasive Micropapillary Breast Carcinoma: Complete Assessment of an Incomplete Pattern

被引：0
|
作者：
Perron, Marjorie [1 ]
Wen, Hannah [1 ]
Hanna, Matthew [1 ]
Brogi, Edi [1 ,2 ]
Ross, Dara [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Weill Cornell Med Coll, New York, NY USA
来源：
MODERN PATHOLOGY | 2020年 / 33卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
241
引用
收藏
页码：235 / 237
页数：3
相关论文
共 50 条
  • [21] HER2 OVER-EXPRESSION IN INVASIVE BREAST CARCINOMA: IMMUNOCYTOCHEMISTRY (ICC) AND IMMUNOHISTOCHEMISTRY (IHC) IN A CORRELATION STUDY
    Haab, G. Acosta
    Lozano, G.
    Paradello, M.
    Isabel, F.
    Sarancone, S.
    Benedetto, M. E.
    Caceres, V.
    ACTA CYTOLOGICA, 2010, 54 (03) : 443 - 443
  • [22] Impact of the 2018 ASCO/CAP HER2 Guideline Updates on HER2 Assessment in Breast Cancer with HER2 Immunohistochemistry Equivocal Results
    Wen, Hannah
    Ventura, Katia
    Xu, Jin
    Ross, Dara
    Dang, Chau
    Robson, Mark
    Norton, Larry
    Morrow, Monica
    Brogi, Edi
    LABORATORY INVESTIGATION, 2019, 99
  • [23] Impact of the 2018 ASCO/CAP HER2 Guideline Updates on HER2 Assessment in Breast Cancer with HER2 Immunohistochemistry Equivocal Results
    Wen, Hannah
    Ventura, Katia
    Xu, Jin
    Ross, Dara
    Dang, Chau
    Robson, Mark
    Norton, Larry
    Morrow, Monica
    Brogi, Edi
    MODERN PATHOLOGY, 2019, 32
  • [24] Hormone Receptor and HER2/Neu Immunohistochemistry in Multifocal/Multicentric Breast Carcinoma
    Covey, S.
    Baker, D. D.
    O'Connor, S. M.
    LABORATORY INVESTIGATION, 2013, 93 : 35A - 35A
  • [25] Hormone Receptor and HER2/Neu Immunohistochemistry in Multifocal/Multicentric Breast Carcinoma
    Covey, S.
    Baker, D. D.
    O'Connor, S. M.
    MODERN PATHOLOGY, 2013, 26 : 35A - 35A
  • [26] In situ hybridization evaluation of HER2 2+(uncertain) breast carcinoma by immunohistochemistry
    Soares, I. C.
    Cirqueira, C. S.
    Ressio, R. A.
    Wakamatsu, A.
    Siqueira, S. A. C.
    Alves, V. A. F.
    HISTOPATHOLOGY, 2010, 57 : 39 - 39
  • [27] Her2 Expression in Urothelial Carcinoma with Micropapillary Morphology: Preferential Overexpresssion by the Micropapillary Component
    Huang, H.
    Jadallah, S.
    Chen, Y-B
    Gopalan, A.
    Fine, S. W.
    Tickoo, S. K.
    Iyer, G. V.
    Dalbagni, G.
    Solit, D.
    Reuter, V. E.
    Al-Ahmadie, H. A.
    MODERN PATHOLOGY, 2013, 26 : 219A - 219A
  • [28] Assessment of HER2 using the 2018 ASCO/CAP guideline update for invasive breast cancer: a critical look at cases classified as HER2 2+ by immunohistochemistry
    Valerie J. Taylor
    Penny J. Barnes
    Sean C. Godwin
    Gillian C. Bethune
    Virchows Archiv, 2021, 479 : 23 - 31
  • [29] Assessment of HER2 using the 2018 ASCO/CAP guideline update for invasive breast cancer: a critical look at cases classified as HER2 2+by immunohistochemistry
    Taylor, Valerie J.
    Barnes, Penny J.
    Godwin, Sean C.
    Bethune, Gillian C.
    VIRCHOWS ARCHIV, 2021, 479 (01) : 23 - 31
  • [30] Invasive micropapillary carcinoma of the breast
    Oakley, S
    Bell, JA
    Pinder, SE
    Elston, CW
    Blamey, RW
    Ellis, IO
    JOURNAL OF PATHOLOGY, 2000, 192 : 20A - 20A
12345